Lack Of VC Industry In Asia Means Public Institutions Need To Step In and Take On Risk
This article was originally published in PharmAsia News
Executive Summary
SINGAPORE - Public institutions will need to step in and narrow the sizable gap between early research and commercialization in much of Asia, experts told an April 16 panel at the BioMedical Asia conference in Singapore
You may also be interested in...
Dx Assays Opens R&D Lab As Singapore’s First Developer Of Molecular Diagnostic Assays
PERTH, Australia - Dx Assays, Singapore's first commercial developer of molecular diagnostic assays, opened its new R&D center in Singapore Sept. 8
Dx Assays Opens R&D Lab As Singapore’s First Developer Of Molecular Diagnostic Assays
PERTH, Australia - Dx Assays, Singapore's first commercial developer of molecular diagnostic assays, opened its new R&D center in Singapore Sept. 8
Singapore Continues To Attract MNCs; Hill-Rom The Latest To Open Innovation Center In Country
SHANGHAI - Worldwide medical technology and device maker Hill-Rom opened its Asia-Pacific Innovation Center in Singapore Aug. 24. The new center will focus on research and development in micro-electronics and embedded software